Philips Expands Global Reach of Diagnostic X-Ray Solutions

PhilipsRoyal Philips (NYSE: PHG AEX: PHIA) has announced expanded availability of its portfolio of diagnostic X-ray solutions, including DuraDiagnost, DigitalDiagnost, MobileDiagnost wDR, MobileDiagnost Opta, ProGrade and PrimaryDiagnost. With new releases of several of these solutions now available in the U.S.A., and availability of all these solutions in new global markets, the portfolio offers Philips' customers innovative solutions designed to meet the needs and overcome the challenges of diagnostic X-ray environments across the world.

"Philips understands that a one-size-fits-all approach in health care just doesn't work. We serve a wide range of customers around the world, and their needs vary depending on a number of factors, including the economic pressures, patient populations and regulatory landscape in their local markets," said Bert van Meurs, General Manager, Integrated Clinical Solutions, Philips Healthcare. "Our diagnostic X-ray portfolio provides meaningful solutions for health care providers looking to take advantage of digital radiography, in any region of the world."

Central to the solutions in the Philips DR portfolio is the new SkyPlate portable detector, which offers cassette-sized wireless sharing across Philips' compatible digital radiography systems. In addition, Philips' SkyFlow technology, available on DigitalDiagnost and MobileDiagnost wDR, keeps providers at the forefront of clinical performance by allowing clinicians to combine the ease of the grid-less acquisition workflow for bedside chest radiography with detail contrast offering grid-like images. The Eleva user interface, designed for fast, consistent workflow results, also offers pre-settings, customizable user profiles and rapid image availability. All systems also share Philips' Unified Image Quality Enhancement (UNIQUE) software that allows for consistent imaging across all anatomical areas, which aims to limit the number of follow-up exams and additional X-ray dose.

From the DuraDiagnost enabling fast exam set up and workflow efficiency, to the DigitalDiagnost designed to address the advanced demands of busy medical facilities, to MobileDiagnost wDR and MobileDiagnost Opta providing bedside, on-the-spot imaging capabilities, the Philips DR suite provides a solution for virtually any clinical environment. The portfolio rounds out with ProGrade, upgrading providers to a fully integrated, digital imaging experience using BuckyDiagnost, and PrimaryDiagnost, which achieved its first installation in July 2014.

"With Philips, we've moved from ordering a piece of equipment to an established long-term partnership. That partnership allows us to take a long view of how we will improve care," said Dr. James V. Rawson, Chief of Radiology Georgia Regents Medical Center. "When we replaced the digital portable X-ray units in the ICU, we completely changed the workflow. After an x-ray was taken in the ICU, the image was immediately available at that bedside for the physician to be able to see. That allowed real-time decisions and corrections or repositioning of lines and repeating at the x-ray, and cut our cycle-time down substantially."

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately 115,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI, Health, and Health Care Today and To…

Artificial intelligence (AI) carries promise and uncertainty for clinicians, patients, and health systems. This JAMA Summit Report presents expert perspectives on the opportunities, risks, and challenges of AI in health...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...

New AI Tool Makes Medical Imaging Proces…

When doctors analyze a medical scan of an organ or area in the body, each part of the image has to be assigned an anatomical label. If the brain is...